Having worked in the British, French and Swiss financial press, Romain is able to report on local and international issues, as comfortable in French as in the language of Shakespeare, Romain Fournier leads the editorial team at Marketscreener. Fine connoisseur of the English-speaking markets, Romain delivers an editorial every day on US and UK markets.
Analyst recommendations: BP, GlaxoSmithKline, Nikola, Papa John's, Qualcomm...
Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.
Ansys: RBC Capital Markets raised the target to $425 from $380. Maintains sector perform rating.
BP Plc: Jefferies maintained his recommendation on the stock with a Neutral rating. The target price differs slightly and is now set at GBp 360 versus GBp 350.
Citrix: Morgan Stanley downgrades to underweight from equal-weight. PT down 11% to $85
CyberArk: Wedbush goes long and raises its target from USD 200 to 230.
Evercore: UBS upgrades its buy rating to neutral but raises its target price from USD 148 to USD 155.
GlaxoSmithKline: Barclays raises its opinion on the stock and goes from selling to neutral. The target price is revised upwards from GBp 1600 to GBp 1400.
London Stock Exchange: Goldman Sachs upgrades his rating from Sell to Buy. The target price continues to be set at GBp 8695.
Microchip: Truist Securities upgrades to $94 from $88. Maintains buy rating.
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
